Vaccine

The vaccine, developed and tested jointly with Oxford University and British pharmaceutical company AstraZeneca, will also be produced in Brazil. The country announced on Saturday that it had signed a 127 million deal with AstraZeneca to...

Coronavirus or Covid-19 vaccine is being developed by various organizations around the world. The most advanced of these is the vaccine developed by Oxford. The Oxford University and pharmaceutical company AstraZeneca’s experimental vaccine has reached the...

world’s leading medical journal Lancet expressed that quicker success of COVID-19 vaccine studies unlike experiences about other inoculates as the globe now witnesses a race among drugmakers and researchers to come up with a vaccine against...

The European Union (EU) has so far raised more than $10 billion in global efforts to develop vaccines and drugs to prevent Covid-19. Experts believe the fund was raised as part of the ongoing efforts of...

US President Donald Trump has said that whether the coronavirus vaccine comes or not, everything will be restarted in the United States. Trump made the remarks at a news conference at the White House’s Rose Garden...

A COVID-19 vaccine may be the only thing that can bring back “normalcy,” UN Secretary-General Antonio Guterres said Wednesday, hoping for just that before the end of the year. “A safe and effective vaccine may be...

A large majority of Americans would be reluctant to attend future sporting events unless a vaccine for the coronavirus is developed, a survey by Seton Hall University has found. With every major sport across North America...

Russian scientists have begun to test vaccine prototypes for the new coronavirus, and plan to present the most effective one by June, a laboratory chief at a state biotech institute said. Russia has reported 93 cases...

The first human trial of a vaccine to protect against pandemic coronavirus has started in the US. Four patients received the jab at the Kaiser Permanente research facility in Seattle, Washington, reports the Associated Press news...

Source of disease prevalence information impacts the effectiveness of vaccination programs. Computational modeling of social networks suggests that vaccination programs are more successful in containing disease when individuals have access to local information about disease prevalence....